CALL/ABBOTT LABORATORIES/150/0.1/17.01.25 Stock

Warrant

DE000GQ9GQR1

Real-time BOERSE MUENCHEN 06:25:25 2024-07-11 am EDT
0.019 EUR -20.83% Intraday chart for CALL/ABBOTT LABORATORIES/150/0.1/17.01.25
Current month-7.69%
1 month-29.41%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 0.019 -20.83%
24-07-10 0.024 -7.69%
24-07-09 0.026 +8.33%
24-07-08 0.024 -4.00%
24-07-05 0.025 +56.25%

Real-time BOERSE MUENCHEN

Last update July 11, 2024 at 06:25 am EDT

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GQ9GQR
ISINDE000GQ9GQR1
Date issued 2024-02-19
Strike 150 $
Maturity 2025-01-17 (191 Days)
Parity 10 : 1
Emission price 0.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.158
Lowest since issue 0.016
Spread 0.03
Spread %62.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103 USD
Average target price
124.8 USD
Spread / Average Target
+21.08%
Consensus